Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HomeRegulatoryClaimsSabinsa Achieves Significant Canadian Health Claim on IBS for Shelf Stable Probiotic LactoSpore

Sabinsa Achieves Significant Canadian Health Claim on IBS for Shelf Stable Probiotic LactoSpore

<p style="margin: 0in 0in 8pt;">Health Canada has issued a Product License to Sabinsa for a significant health claim on LactoSpore&reg; Balance: &ldquo;Helps relieve abdominal pain associated with IBS.&rdquo;</p>
TAGS: Archive Probiotics & Prebiotics Regulatory
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
supplement claims.jpg
FDA’s stance on mental health claims
Sep 03, 2021
probiotic strains.jpg
Strain specificity vital to probiotic efficacy
Sep 02, 2021
immune-supplements.jpeg
Post-pandemic perspectives on immune-health products
Jul 23, 2021
market analysis.jpg
CBD’s slowdown: What went wrong for the industry in 2020
Jul 16, 2021